Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.

White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group.

Diabetes Care. 2009 Mar;32(3):387-93. doi: 10.2337/dc08-0800. Epub 2008 Dec 23.

2.

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL.

J Clin Endocrinol Metab. 2008 Apr;93(4):1238-45. doi: 10.1210/jc.2007-2212. Epub 2008 Jan 22.

PMID:
18211968
3.

Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA; KIGS International Board.

Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85.

PMID:
16886957
4.

Puberty-timing is everything!

Pinyerd B, Zipf WB.

J Pediatr Nurs. 2005 Apr;20(2):75-82. Review.

PMID:
15815567
5.
6.

Risk factors for coronary heart disease in type 1 diabetic children: the influence of apoE phenotype and glycemic regulation.

Tso TK, Snook JT, Lozano RA, Zipf WB.

Diabetes Res Clin Pract. 2001 Dec;54(3):165-71.

PMID:
11689271
7.

Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose.

Chang CK, Tso TK, Snook JT, Huang YS, Lozano RA, Zipf WB.

Acta Diabetol. 2001;38(1):37-42.

PMID:
11487175
9.
10.

Mosaicism in Prader-Willi syndrome.

Mowery-Rushton PA, Hanchett JM, Zipf WB, Rogan PK, Surti U.

Am J Med Genet. 2000 Jan 17;90(2):177. No abstract available.

PMID:
10722401
11.

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.

Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW 3rd, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Zipf WB, et al.

Diabetes Res Clin Pract. 1999 Aug;45(1):61-73. Review. No abstract available.

PMID:
10499886
12.

Sandwich enzyme-linked immunosorbent assay for plasma cholesteryl ester transfer protein concentration.

Chang CK, Tso TK, Snook JT, Zipf WB, Lozano RA.

Clin Biochem. 1999 Jun;32(4):257-62.

PMID:
10463817
13.

Splanchnic uptake of leucine in healthy children and in children with cystic fibrosis.

Kien CL, Horswill CA, Zipf WB, McCoy KS, Denne SC.

Pediatr Res. 1999 May;45(5 Pt 1):680-3.

PMID:
10231864
15.
16.

Pancreatic polypeptide: identification of target tissues using an in vivo radioreceptor assay.

Shetzline MA, Zipf WB, Nishikawara MT.

Peptides. 1998;19(2):279-89.

PMID:
9493860
17.

Food preferences in Prader-Willi syndrome, normal weight and obese controls.

Fieldstone A, Zipf WB, Schwartz HC, Berntson GG.

Int J Obes Relat Metab Disord. 1997 Nov;21(11):1046-52.

PMID:
9368829
18.

Measuring energy costs of leisure activity in adolescents using a CO2 breath test.

Horswill CA, Zipf WB, Kien CL.

Med Sci Sports Exerc. 1997 Sep;29(9):1263-8.

PMID:
9309640
19.
20.

Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.

Schuster DP, Osei K, Zipf WB.

Metabolism. 1996 Dec;45(12):1514-20.

PMID:
8969285

Supplemental Content

Loading ...
Support Center